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Introduction: The mechanisms of lung repair and fibrosis in the acute respiratory distress syndrome (ARDS) are
poorly known. Since the role of WNT/β-catenin signaling appears to be central to lung healing and fibrosis, we
hypothesized that this pathway is activated very early in the lungs after sepsis.
Methods: We tested our hypothesis using a three-step experimental design: (1) in vitro lung cell injury model with
human bronchial epithelial BEAS-2B and lung fibroblasts (MRC-5) cells exposed to endotoxin for 18 hours; (2) an
animal model of sepsis-induced ARDS induced by cecal ligation and perforation, and (3) lung biopsies from patients
who died within the first 24 hours of septic ARDS. We examined changes in protein levels of target genes involved
in the Wnt pathway, including WNT5A, non-phospho (Ser33/37/Thr41) β-catenin, matrix metalloproteinase-7
(MMP7), cyclin D1, and vascular endothelial growth factor (VEGF) by Western blotting and immunohistochemistry.
Finally, we validated the main gene targets of this pathway in experimental animals and human lungs.
Results: Protein levels of WNT5A, non-phospho (Ser33/37/Thr41) β-catenin, total β-catenin, MMP7, cyclin D1, and
VEGF increased after endotoxin stimulation in BEAS-2B and MRC-5 cells. Lungs from septic animals and from septic
humans demonstrated acute lung inflammation, collagen deposition, and marked increase of WNT5A and MMP7
protein levels.
Conclusions: Our findings suggest that the WNT/β-catenin signaling pathway is activated very early in sepsis-induced
ARDS and could play an important role in lung repair and fibrosis. Modulation of this pathway might represent a
potential target for treatment for septic and ARDS patients.Introduction
Acute respiratory distress syndrome (ARDS) is a severe
inflammatory process caused by pulmonary or systemic
insults to the lung alveolar-capillary barrier [1-3]. Sepsis
is the most common predisposing factor underlying
ARDS and is characterized by systemic inflammation in
response to circulating microbes or microbial toxins
such as lipopolysaccharide (LPS), also termed endotoxin,
a component of the cell wall of gram-negative bacteria.
Sepsis and sepsis-induced ARDS are common syndromes
associated with high morbidity and mortality [1,2,4].
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unless otherwise stated.proliferation and migration of type-II alveolar epithelial
cells, and their differentiation into type-I alveolar cells [1,5].
In addition, lung fibroblast migration and proliferation
occur early after lung injury and are necessary for ongoing
lung healing [6-8]. Damage to the alveolar epithelium
can lead to abnormal repair that culminates in a vigorous
fibroblastic response, leading to uncontrolled extracellular
matrix deposition and destruction of lung parenchymal
architecture [8,9].
The role of β-catenin-mediated wingless integration
(Wnt) signaling is proving to be central to mechanisms
of lung healing and fibrosis [10,11]. Tissue repair involves
re-epithelialization, in which injured cells are replaced by
cells of the same type and normal parenchyma may
be replaced by connective tissue leading to fibrosis [11].
Königshoff et al. [10] showed that WNT ligands induce
lung epithelial cell proliferation, fibroblast activation, andd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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induced lung injury model and also in humans with
idiopathic pulmonary fibrosis. Wnt binding to cognate
Frizzled receptors results in cytosolic accumulation of
β-catenin, which then translocates to the nucleus and
participates in gene transcription [11-13]. Wnt/β-ca-
tenin signaling stimulates tissue remodeling and wound
closure, or tissue remodeling and destruction through
matrix metallopeptidases (MMPs) and other gene
products [14]. This activation stimulates many of the
pro-inflammatory cytokines participating in inflammation-
mediated lung destruction and hyaline membrane forma-
tion [12], and induces expression of growth-associated
genes such as cyclin D1 and vascular endothelial growth
factor (VEGF) [15]. MMP7 (also known as matrilysin) is a
target gene of the Wnt signaling pathway found on the
surface of lung epithelial cells and is a key regulator of
pulmonary fibrosis [16].
In the present study, we examined the hypothesis that
the Wnt/β-catenin pathway is activated in the lungs very
early after sepsis and plays a role in initiating the lung
repair process. To test this hypothesis we used a well-
established LPS-induced cell injury model using human
lung cells based on the first steps in the development of
sepsis and sepsis-induced ARDS [17-21]. Then, we val-
idated the main gene targets of this pathway in a clinically
relevant murine model of sepsis-induced ARDS by cecal
ligation and perforation (CLP), and in lung biopsies




We used healthy human bronchial epithelial BEAS-2B
cells (ATCC, Manassas, VA, USA) and human lung
MRC-5 fibroblasts. BEAS-2B cells were cultured as pre-
viously described [17] in Dulbecco’s modified Eagle’s
medium supplemented with 10% FBS and penicillin and
streptomycin, at 37°C in a 5% CO2, 95% humidified air in-
cubator. MRC-5 cells were obtained from the Department
of Microbiology (Hospital Universitario Dr Negrín, Las
Palmas, Spain) and cultured in RPMI-1640 medium
with 10% FBS under the same experimental conditions.
We chose human BEAS-2B and MRC-5 cells as repre-
sentative lines for studying changes during acute lung
injury because these cell lines have been validated pre-
viously in experimental models addressing the first
steps of sepsis-induced ARDS [18-24]. For all experi-
ments, BEAS-2B and MRC-5 cells were stimulated
with 100 ng/mL of LPS obtained from Escherichia coli
(Sigma-Aldrich, St Louis, MO, USA), a concentration
used in previous studies for induction of inflammatory
responses [18,21] and validated to study LPS-induced
effects [22].Inhibition of cell proliferation
BEAS-2B and MRC-5 cells were suspended in 5 × 106
cells/flask and inoculated in 75 cm2 flasks. After 24 h,
cells were exposed or not, to LPS (100 ng/mL) for 18 h,
and then examined and photographed (Olympus Camedia
digital camera) under a phase-contrast microscope
(Olympus CK-40 F-200, Tokyo, Japan). The effects of LPS
on cell growth were assessed using the Sulforhodamine B
colorimetric assay (SRB, Sigma-Aldrich) [25] (see Additional
file 1 for details).
Western blotting
Protein levels of WNT5A, total β-catenin, non-phospho
(Ser33/37/Thr41) β-catenin, MMP7, cyclin D1, and VEGF
were measured by western blotting. For total protein
extracts, cells were homogenized in radioimmunopre-
cipitation assay (RIPA) protein extract buffer, as described
previously [26] (see Additional file 1 for further details).
Bands were detected by chemiluminescence (Amersham
Reagents, GE Healthcare, Fairfield, CN, USA) and blots
were measured by Scion Image software package (Scion
Corp, Frederick, MD, USA).
In vivo experimental animal model
In an attempt to translate the in vitro observations into the
disease state of interest (sepsis and ARDS), we performed
histological and immunohistochemical examination of
lungs from a clinically relevant experimental animal
model of sepsis-induced lung injury. The experimental
protocol was approved by the Animal Care Committee
at the Hospital Universitario Dr Negrin, Las Palmas de
Gran Canaria, Spain (CEEBA#003/10), in accordance
with the European Commission Directive 2010/63/EU for
animal experimentation. This study followed the guide-
lines, Animal Research: Reporting of in Vivo Experiments
(ARRIVE), for reporting animal research [27].
We studied eight healthy male Sprague-Dawley rats
weighing 300 to 350 g. After anesthesia with intraperito-
neal injection of xylazine and ketamine hydrochloride, an-
imals were randomized to control (sham-sepsis) (n = 3) or
sepsis (n = 5). Sepsis was induced by CLP. A detailed de-
scription of this experimental model is provided elsewhere
[28]. Sham-CLP underwent the same surgical procedures
as CLP rats: the cecum was exposed (but not ligated or
punctured) and returned to the abdominal cavity, and the
abdominal wall was then sutured. Eighteen hours later,
control animals and the first three surviving septic animals
were anesthetized and sacrificed. A midline thoracotomy/
laparotomy was performed and the heart and lungs were
removed en bloc. The lungs were isolated from the heart,
the trachea was cannulated, and the right lung was fixed
by intratracheal instillation of 3 mL of 10% formalin and
floated in 10% formalin for a week. Lungs were serially
sliced from apex to base and embedded in paraffin, cut
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and eosin for microscope observation. Two pathologists
(FV, SGH) were blinded to the sample identity. Three
random sections from each animal were examined with
particular reference to alveolar and interstitial damage
defined by the presence of pulmonary edema, inflamma-
tory cell infiltration, vascular congestion, and fibrosis.
Slides were viewed using a Nikon Optiphot 2 microscope
and photographed in a Nikon Digital Sight DS-5 M cam-
era (Tokyo, Japan) at × 200 magnification.
We also used the Sirius-red staining technique [29] for
assessment of collagen content, as described elsewhere
[30]. We defined fibrosis as the presence of collagen.
With this technique, collagen fibers are stained bright
red and nuclei/cytoplasm are bright yellow. Slides were
viewed with an Olympus (Bx50) microscope and
photographed with an Olympus digital camera at × 200
magnification.
Human lung tissue from autopsies
For translating the in vitro and in vivo observations into
the human disease state of interest (sepsis and ARDS),
we performed histological and immunohistochemical
examination of human lungs from patients who died
very early in their course of severe sepsis. Two patholo-
gists (FV, SGH) analyzed the lungs of 12 patients from
the archives of autopsies performed between 2007 and
2012 at the Department of Pathology of the University
of La Laguna Medical School, Tenerife, Spain. A waiver
of ethics was granted by the Ethics Committee for
Clinical Research at the Hospital Universitario de
Canarias (Tenerife, Spain), as informed consent is sys-
tematically obtained from patients’ relatives for both
clinical autopsy and potential use of tissue samples in
teaching and research purposes. An anonymized sum-
mary with clinical relevant information of patients who
have had an autopsy is stored in a specific database of
the Department of Pathology for further review when
necessary. Control lungs were selected from six autop-
sies in patients who died from diseases without any
lung involvement. Septic lungs were selected from
autopsies performed in six patients meeting standard
criteria for severe sepsis [4] and ARDS [1-3], who did
not receive mechanical ventilation and died within the
first 24 h of developing severe sepsis. Pathologists were
asked to select the autopsies of interest following a
strict chronological order, starting with those performed
in 2012 and continuing yearly backwards, without any
preference or selection bias. After identification of the
patients from the postmortem examination, they checked
with the institutional database to confirm the clinical
diagnosis.
Paraffin blocks of lung tissue collected during autopsy
were retrieved from the Department of Pathology archives.In the routine autopsies, three to four fragments of lung
parenchyma are obtained. In normal lungs, one fragment of
lung tissue was collected from each lobe. The tissue had
been fixed in 10% buffered formalin, routinely processed
and paraffin embedded. Sections of 3-μm thickness were
stained with hematoxylin and eosin and the Sirius-red
technique, and evaluated for acute lung injury and collagen
content.
Immunocytochemistry
Immunocytochemical stains were performed by applying a
standard avidin-biotin complex technique (see Additional
file 1 for further details). To view slides, we used an Olym-
pus BX50 microscope and an Olympus Camedia digital
camera at × 400 magnification.
Statistical analysis
For the statistical power analysis for sample size calcu-
lations in both categories of autopsies (diseases with
no lung involvement, septic ARDS), we estimated that
to detect at least a 2-fold increase in the immunostain-
ing intensity of fibrotic markers (WNT5A, MMP7) in
septic lungs compared to the basal intensity in patients
without sepsis, we would require six patients in each
group, with an alpha of 0.05 and a power greater than
0.80.
Data are expressed as mean ± SD, and were analyzed
using Graph Pad Prism software version 5.0. Data are
from different experiments and samples within each
group. Comparisons involving all experimental cell groups
were performed with one-way analysis of variance. We
used the Bonferroni correction for multiple comparisons.
For western blot experiments, densitometry data of the
non-phospho (Ser33/37/Thr41) β-catenin bands were
normalized to β-catenin and β-actin (as loading con-
trols), and densitometry of the active form (20 kDa) of
MMP7 was normalized to the inactive form (30 kDa) and
then normalized to β-actin. Data are from at least three




LPS decreased the proliferation of MRC-5 and BEAS-2B
cells. The maximum effect on cell viability in both cell
types was observed at 18 h using 100 ng/mL LPS (data
not shown).
WNT5A and associated proteins
WNT5A protein levels were significantly increased in
MRC-5 and BEAS-2B cells (P <0.001) after LPS expos-
ure (Figures 1A and 2A, respectively). LPS stimulation
led to a significant increase in non-phospho (Ser33/37/
Thr41) β-catenin (Figures 1B, 2B). The active form of
Figure 1 Activation of WNT5A/β-catenin pathway by E. coli lipopolysaccharide (LPS) in human BEAS-2B cells. (A) Changes in total
WNT5A, cyclin D1, metallopeptidase (MMP)7 and vascular endothelial growth factor (VEGF) proteins (representative blots and mean densitometric
values) following LPS stimulation for 18 h. Densitometry analysis of the active form (20 kDa) of MMP7 was normalized to the inactive form
(30 kDa) and then normalized to β-actin. (B) Changes in non-phosphorylated (Ser33/37/Thr41) β-catenin protein bands were normalized to total
β-catenin and β-actin. ***P <0.001 versus control-vehicle (C).
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BEAS-2B cells stimulated with LPS. LPS treatment also
caused increased upregulation of cyclin D1 and VEGF
(Figures 1A, 2A). Immunocytochemical staining de-
tected non-phospho Ser33/37/Thr41 β-catenin at the
nuclei of MRC-5 and BEAS-2B cells stimulated with
LPS (Figure 3).
Animal model
CLP induced typical signs of disease including lethargy,
ruffled fur, generalized weakness, reduced gross motor
activity, and weight loss, accordingly with the literature
[28]. Three out of five septic animals survived 18 h
after CLP, and these animals were studied further.
Lungs from septic animals showed acute inflammatory
infiltrates, perivascular edema and collagen deposition
in the parenchyma (Figure 4, panel B). The Sirius-red
staining for collagen was negative in control animals
(Figure 4, panel D). Healthy control animals had a
basal intensity of WNT5A and MMP7 whereas septiclungs showed strong immunohistochemistry intensity
of WNT5A and MMP7 (Figure 4, panels F and H).
Human lungs from autopsies
Clinical diagnoses of six patients who died with septic
ARDS and six control subjects who died from non-
pulmonary causes within 24 h of disease onset are pre-
sented in Table 1. No relevant findings were found in the
lungs from patients who died without lung disease. Lungs
from septic patients showed features of diffuse lung
damage, manifested by acute inflammatory infiltrates and
perivascular edema (Figure 5, panel B). Lungs from septic
patients showed high intensity of collagen-rich areas in
the parenchyma, providing evidence of the presence of a
fibrotic response in the early stages of sepsis-induced lung
injury (Figure 5, panel D). Lungs from patients without
pulmonary disease had a basal intensity of WNT5A and
MMP7 whereas lungs from septic patients showed a
strong immunohistochemical intensity of WNT5A and
MMP7 (Figure 5, panels F and H)
Figure 2 Representative western blots for WNT5A/β-catenin pathway stimulated by LPS in human MRC-5 cells. (A) Changes in total
WNT5A, cyclin D1, metallopeptidase (MMP)7 and vascular endothelial growth factor (VEGF) proteins following exposure to 100 ng/mL lipopolysaccharide
(LPS) stimulation for 18 h. Densitometry analysis of the active form (20 kDa) of MMP7 was normalized to the inactive form (30 kDa) and then normalized to
β-actin. (B) Changes in non-phospho Ser33/37/Thr41 β-catenin after 18 h of LPS stimulation. Densitometry was performed on at least three different blots
per condition and normalized to the respective loading control (β-actin). Protein expression is expressed as fold-change relative to the respective
control vehicle (C). ***P <0.001 versus control vehicle (C).
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We examined the translational impact of the WNT/β-
catenin pathway in an LPS-induced human lung cell
injury model and validated the main gene targets of this
pathway in the lungs of septic experimental animals and
in human lungs from autopsies. The major findings of
our study are: (1) WNT5A is expressed very early by
human airway epithelial cells and lung fibroblasts in
response to LPS; (2) upregulation of WNT5A expres-
sion and non-phospho Ser33/37/Thr41 β-catenin are
associated with upregulation of downstream target
genes that are involved in profibrotic transformation of
injured tissues, such as MMP7, cyclin D1 and VEGF;
and (3) pulmonary fibrosis is induced very early during
sepsis-induced ARDS, both experimentally and clinically.
These findings suggest that WNT5A and β-catenin con-
tribute very early to repair the damage to lung tissue and
may play a role in restructuring lung architecture during
sepsis-induced ARDS.We selected BEAS-2B and MRC-5 cell lines as repre-
sentative human airway epithelial cells and lung fibro-
blasts because these cells have been implicated in the
pathogenesis of sepsis-induced ARDS [18-24] and subse-
quent fibrosis [31]. These cell models provide a powerful
translational in vitro approach for recapitulating human
ARDS. LPS-treated human BEAS-2B cells are an accepted
and validated in vitro cell injury model of the acute lung
inflammatory response based on the first steps in the de-
velopment of sepsis and sepsis-induced ARDS [18]. Lung
airway epithelial cells and fibroblasts generate various im-
mune effectors such as cytokines, chemokines, and several
peptides in response to inflammatory stimuli [23,32],
which control lung inflammation, lung injury and lung
repair [9,12,31,33]. We selected E. coli LPS because it
has been used in most endotoxin-induced lung injury
models [21,34] and LPS is a key pathogen recognition
molecule for sepsis [33,34]. Because previous in vitro
studies using LPS-stimulated airway epithelial cells and
Figure 3 Non-phospho Ser33/37/Thr41 β-catenin immunolo-
calization on BEAS-2B and MRC-5 cells stimulated with
lipopolysaccharide (LPS). Red-pink colour indicates positive staining
(3-amino-9-ethylcarbazole) for non-phospho Ser33/37/Thr41 β-catenin
protein. Non-phospho Ser33/37/Thr41 β-catenin staining was found in
nuclei (large arrows) in cells stimulated with LPS but not in control-vehicle
cells (C). The images (at × 200 magnification) are representative of
experiments performed in triplicate. Scale bars = 20 μm.
Table 1 Clinical diagnosis of patients with non-pulmonary
diseases and sepsis-induced acute lung injury
Main diagnosis Cause/mechanism of death
Non-pulmonary diseases
Acute myocardial infarction Ventricular fibrillation
Acute myocardial infarction Left ventricular rupture
End-stage colon cancer Myocardial infarction
End-stage liver cirrhosis Liver failure
Coronary artery disease Severe cardiac arrhythmias
Epilepsy, Down syndrome Severe hypoxic encephalopathy
Sepsis-induced lung injury
Acute peritonitis Septic shock
AIDS Pneumonia
Pneumonia Septic shock
Abdominal sepsis Septic shock
Abdominal sepsis Septic shock
Pneumonia Septic shock
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mediators and increased cytokine release [20,35,36], we
examined the modulation of WNT5A, β-catenin, MMP7,
cyclin D1 and VEGF molecules that contribute to lung
repair and fibrosis [12,16,37].
We extended our in vitro findings by confirming that
collagen synthesis and the main target gene products ofFigure 4 Representative histological features of healthy and septic ra
activation in healthy and septic rat lungs. (A-D) Histological features: (A
infiltrates and perivascular edema; (C) normal lung (healthy) and (D) septic
magnification). (E-H) Red-pink color indicates positive staining for WNT5A (
nuclei counterstained with hematoxylin. WNT5A and MMP7 were observedthis pathway (WNT5A, MMP7) increased in a clinically
relevant model of sepsis-induced lung injury and in lungs
from patients who died with severe sepsis and ARDS. We
used CLP as a clinically relevant and well characterized
animal model to explore the fibrotic transformation in
the lungs during the first 24 h of sepsis. CLP induced a
reproducible and consistent septic and sepsis-induced
ARDS condition in accordance with previous studies
[17,28]. Histopathological features of CLP-induced ARDSt lungs and immunohistochemical staining for WNT5A and MMP7
) normal lung (healthy) and (B) septic lung showing pulmonary
lung stained with Sirius-red assay for collagen content (× 200
E, F) and metallopeptidase (MMP)7 (G, H) and blue/violet indicates
in alveolar walls and septa (× 200 magnification).
Figure 5 Representative histological features of healthy and septic human lungs and immunohistochemical staining for WNT5A and
MMP7 activation in normal and septic human lungs. (A-D) Histological features: (A) normal lung (healthy) and (B) septic lung showing
pulmonary infiltrates and perivascular edema; (C) normal lung and septic lung (D) stained with Sirius-red assay for collagen content (× 200
magnification). (E-H) WNT5A (E, F) and metallopeptidase (MMP)7 (G, H) are shown in red-pink color. Tissues were counterstained with
hematoxylin. There was increased immunoreactivity for WNT5A and MMP7 in alveolar walls and septa (× 200 magnification).
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acute inflammatory infiltrates. Lung tissue damage is
observed in 90% of patients dying from sepsis [38].
Moreover, lung cells can activate mechanisms for initiating
tissue repair, a process which involves re-epithelialization;
injured cells are replaced by cells of the same type, but in
some cases, normal parenchyma is replaced by connective
tissue leading to fibrosis [11]. There is evidence of fibrotic
changes in the earliest stages of ARDS [26,39,40]. β-catenin
signaling stimulates tissue remodeling, cell migration,
and wound closure through MMPs, but if the process is
uncontrolled, it can drive tissue destruction through
MMPs and other mediators [11]. Wnt ligands induce
lung epithelial cell proliferation, fibroblast activation
and collagen synthesis [16]. Collagen and other matrix
extracellular molecules are the main components of the
extracellular matrix, and MMP7 is a key mediator of
pulmonary fibrosis [16].
Several Wnt genes are expressed in the developing and
adult lung. Of these, Wnt5a and Wnt7b are expressed at
high levels in the airway epithelium [14]. We chose to
examine the modulation of WNT5A because it has been
implicated in several pulmonary disorders [11] and has
not been studied in the context of sepsis and LPS-induced
ARDS. In our study, WNT5A was detected with moderate
intensity in alveolar walls and septa in the lungs of CLP
rats and in the lungs of humans who died with early septic
ARDS. Blumenthal et al. [41] reported that the expression
of WNT5A required Toll-like receptor signaling and
NF-κB activation. In a previous report by our group,and using the same epithelial cell injury model as in
the present study, we showed that LPS modulated the
NF-κB activation through the Toll-like receptor signaling
[22]. The fact that β-catenin is rapidly upregulated in our
epithelial/fibroblast cell injury model suggests that the
WNT/β-catenin pathway could be continuously stimulated
during ARDS and it could be a mechanism for perpetuating
lung injury or for initiating lung repair. Thus, the activation
of Wnt signaling after sepsis-induced ARDS likely rep-
resents a regenerative signal of the damaged epithelium
[42]. Using expression microarrays, Vuga et al. [43]
showed that WNT5A was significantly increased in
fibroblasts isolated from lung tissues of patients with
lung fibrosis compared with fibroblasts from normal
lung tissues. They also reported increased cell prolifera-
tion when normal lung fibroblasts were treated with
WNT5A.
Our findings parallel those of Chilosi et al. [44] who
found aberrant WNT/β-catenin pathway activation in
lungs from patients with idiopathic pulmonary fibrosis,
suggesting that this pathway could be responsible for
dysfunctional lung repair processes leading to severe and
irreversible pulmonary remodeling. This is a relevant
translational finding because the development of pul-
monary fibrosis has been found to have a direct correl-
ation with severity of lung injury and mortality in ARDS
patients [45]. The cell cycle regulatory molecule cyclin D1
gene is one of the target genes for the Wnt/β-catenin sig-
naling pathway, and VEGF is required for maintenance of
adult lung alveolar structures. Any tissue repair involves
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matrix deposition and re-epithelialization. Proteolytic
degradation of the extracellular matrix requires MMPs
which are regulated by Wnt signaling. It is uncertain
why ARDS resolution involves fibrosis in some patients
but not in others. Using western blot analysis of Wnt
target gene products cyclin D1 and MMP7, Königshoff
et al. [16] demonstrated increased functional Wnt/β-ca-
tenin signaling in pulmonary fibrosis compared with
patients without pulmonary fibrosis. Zuo et al. [46] ana-
lyzed samples from patients with pulmonary fibrosis
using microarray technology and found that Mmp7 was
the most upregulated gene, a finding that was confirmed
by immunohistochemistry. The increased expression of
cyclin D1, VEGF, and MMP7 in our study supports the
importance of Wnt signaling in perpetuating lung in-
flammation and provides insights into the early develop-
ment of a pro-fibrotic response during sepsis-induced
ARDS. A greater understanding of modulators of WNT
expression and the effects of WNT proteins in similar
models will be paramount for clarifying the role of this
pathway in lung inflammation and repair.
Our study does have some limitations. First, although
the animal model used in the present investigation was
CLP, we have examined autopsies from patients with
different types of septic ARDS. However, there are no data
suggesting that there is anything specific about pulmonary
versus non-pulmonary insults in terms of different pul-
monary fibrotic responses during severe sepsis. In an acid
aspiration lung injury model, we found a similar fibrotic
transformation as in our septic model [26]. A recent study
[40] has shown that pulmonary fibrosis represents an early
pathologic response in patients with ARDS, independent
of the pulmonary or extrapulmonary nature of its cause.
Second, we did not explore the effects of inhibitors of the
Wnt pathway to irrefutably demonstrate that activation of
Wnt pathway in the lung by a septic insult is responsible
for the upregulation of downstream target genes (such
as MMP7, cyclin D1, VEGF) that are involved in the
pro-fibrotic transformation of injured tissues. However,
studies by other investigators on selective inhibition of
the Wnt/β-catenin signaling pathway [44,47,48] have
indicated that the WNT/β-catenin pathway is a target
for anti-inflammatory and anti-fibrotic actions.
Conclusion
In summary, our findings suggest that the WNT/β-ca-
tenin pathway may contribute to ongoing lung inflam-
mation and lead to a pro-fibrotic response in the early
stages of ARDS. We observed increased expression of
WNT5A, cyclin D1, VEGF, and MMP7, all of which are
Wnt target gene products that play an important role in
pulmonary fibrosis. Further studies are needed to fully
address unresolved questions regarding the modulationof the Wnt signaling pathway for attenuating lung
inflammation and enhancing lung resolution and repair
as a preventive or therapeutic approach in the setting of
sepsis-induced ARDS.Key messages
 The role of Wnt signaling is proving to be central to
mechanisms of lung healing and fibrosis
 Wnt/β-catenin pathway is activated in the lungs
very early after sepsis and plays a role in initiating
the lung repair process
 Modulation of the Wnt/β-catenin pathway might
represent a potential target for treatment in patients
with sepsis and ARDS-induced pulmonary fibrosisAdditional file
Additional file 1: Supplementary information on methods for: (i)
morphological analysis and inhibition of cell proliferation, (ii)
western blot analysis, and (iii) immunohistochemistry.
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